Shares

News for Investors
Medios Shares at a Glance 

Stock Information

ISIN
DE000A1MMCC8 / WKN A1MMCC
DE000A409682*

Share Class
No-par Value Bearer Shares

Stock Exchange Sectors / Places of Trading
Regulated Market Frankfurt (Prime Standard)
Member of the SDAX index

Open Market Stuttgart and Duesseldorf
Trade Gate

*Note pursuant to Sec. 7 German Stock Exchange Admission Regulation (Börsenzulassungsverordnung – BörsZulV): From a capital increase in kind registered with the commercial register on 11 June 2024, 1,700,000 newly issued shares came into existence, which bear a separate ISIN (DE000A409682) and which are currently not admitted to trading.

Paying Agent
Bank M – Representation of FinTech Group Bank AG
Mainzer Landstraße 61, 60329 Frankfurt

Share Capital / Number of Shares
€25,505,723 / 25,505,723 no-par Value Bearer Share

Shareholder Structure

58.5% Free float
 • 4.9% Paladin Asset Management*
 • 4.7% SEB Investment Management AB

19.7% Martin Hesse
 • Incl. attribution of BMSH GmbH

15.1% Luxempart Invest S.á.r.I.

6.7% Bencis Capital Partners B.V.**

 

* Paladin Asset Management Investment stock corporation with variable capital and sub-funds

** In the course of a capital increase in kind in connection with the acquisition of Ceban Pharmaceuticals B.V., 1,700,000 new shares (ISIN DE000A409682) have been issued to Bencis Buyout Fund V GP B.V., acting for the risk and for the account of Bencis Buyout Fund V C.V., Amsterdam, the Netherlands („Bencis"). These new shares are subject to a lock-up agreement entered into between Medios AG and Bencis, pursuant to which the disposal of the new shares is restricted for a period of 24 months upon completion of the transaction. Therefore, these shares will not be admitted to trading during the lock-up period.

All figures according to voting rights notifications of the notifying parties
Share capital: €25,505,723

To our knowledge, the following sell-side analysts regularly cover and research the Medios share:

InstituteAnalyst
BerenbergSam England
Bryan, Garnier & CoMaria Vara
Deutsche BankMichael Kuhn
Hauck Aufhäuser Investment BankingAlexander Galitsa
JefferiesN.N.
Kepler CheuvreuxMatthias Maenhaut
Metzler Capital MarketsAlexander Neuberger
Warburg ResearchMichael Heider

Stay Informed

Receive e-mail updates on the latest news and the publication of financial reports. This will automatically keep you up to date.

Registration is free of charge and can be revoked at any time.

Click here to register

Claudia Nickolaus
Head of Investor & Public Relations ESG Communications   

+49 30 232 566 800   
ir@medios.group

About Medios

Specialty Pharma

People & Career

Back to Top